Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Lenhard

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
BMC Research Notes|October 6, 2012
Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patientsChristoph Scholz, Sabine Heublein, Miriam Lenhard, et al.
Journal of Ovarian Research|January 24, 2013
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)Sabine Heublein, Thomas Vrekoussis, Doris Mayr, et al.
Investigational New Drugs|November 29, 2008
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosisAnsgar Brüning, Petra Burger, Marianne Vogel, et al.
Clinical Chemistry and Laboratory Medicine|October 25, 2012
Human epididymis protein 4 (HE4) in benign and malignant diseasesLinda Hertlein, Petra Stieber, Angela Kirschenhofer, et al.
Archives of Gynecology and Obstetrics|February 25, 2010
Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patientsLinda Hertlein, Miriam Lenhard, Angela Kirschenhofer, et al.
Clinical Chemistry and Laboratory Medicine|May 9, 2007
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumoursMiriam Lenhard, Caroline Kuemper, Nina Ditsch, et al.
Plos One|August 17, 2013
The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patientsSabine Heublein, Doris Mayr, Thomas Vrekoussis, et al.
International Journal of Molecular Sciences|August 29, 2014
The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumorsSabine Heublein, Doris Mayr, Klaus Friese, et al.
Cancer Biology & Therapy|December 25, 2008
Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosisAnsgar Brüning, Petra Burger, Marianne Vogel, et al.
Biochemical and Biophysical Research Communications|November 13, 2008
Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cellsAnsgar Brüning, Marianne Vogel, Petra Burger, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
BMC Research Notes|October 6, 2012
Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patientsChristoph Scholz, Sabine Heublein, Miriam Lenhard, et al.
Journal of Ovarian Research|January 24, 2013
Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)Sabine Heublein, Thomas Vrekoussis, Doris Mayr, et al.
Investigational New Drugs|November 29, 2008
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosisAnsgar Brüning, Petra Burger, Marianne Vogel, et al.
Clinical Chemistry and Laboratory Medicine|October 25, 2012
Human epididymis protein 4 (HE4) in benign and malignant diseasesLinda Hertlein, Petra Stieber, Angela Kirschenhofer, et al.
Archives of Gynecology and Obstetrics|February 25, 2010
Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patientsLinda Hertlein, Miriam Lenhard, Angela Kirschenhofer, et al.
Clinical Chemistry and Laboratory Medicine|May 9, 2007
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumoursMiriam Lenhard, Caroline Kuemper, Nina Ditsch, et al.
Plos One|August 17, 2013
The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patientsSabine Heublein, Doris Mayr, Thomas Vrekoussis, et al.
International Journal of Molecular Sciences|August 29, 2014
The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumorsSabine Heublein, Doris Mayr, Klaus Friese, et al.
Cancer Biology & Therapy|December 25, 2008
Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosisAnsgar Brüning, Petra Burger, Marianne Vogel, et al.
Biochemical and Biophysical Research Communications|November 13, 2008
Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cellsAnsgar Brüning, Marianne Vogel, Petra Burger, et al.
Pageof 4